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Abstract
Epistasis refers to the phenomenon in which phenotypic consequences caused by mutation of one gene depend
on one or more mutations at another gene. Epistasis is critical for understanding many genetic and evolutionary
processes, including pathway organization, evolution of sexual reproduction, mutational load, ploidy, genomic com-
plexity, speciation, and the origin of life. Nevertheless, current understandings for the genome-wide distribution of
epistasis are mostly inferred from interactions among one mutant type per gene, whereas how epistatic interaction
partners change dynamically for different mutant alleles of the same gene is largely unknown. Here we address this
issue by combining predictions from flux balance analysis and data from a recently published high-throughput ex-
periment. Our results show that different alleles can epistatically interact with very different gene sets. Furthermore,
between two random mutant alleles of the same gene, the chance for the allele with more severe mutational conse-
quence to develop a higher percentage of negative epistasis than the other allele is 50-70% in eukaryotic organisms,
but only 20-30% in bacteria and archaea. We developed a population genetics model that predicts that the observed
distribution for the sign of epistasis can speed up the process of purging deleterious mutations in eukaryotic organ-
isms. Our results indicate that epistasis among genes can be dynamically rewired at the genome level, and call on
future efforts to revisit theories that can integrate epistatic dynamics among genes in biological systems1.
1 Introduction
Epistasis between two deleterious mutations is positive when a double mutant causes a weaker mutational defect
than predicted from individual deleterious mutations, and is negative when the double mutant causes a larger defect
[3, 4]. In a population with sexual reproduction, positive epistasis alleviates the total harm when multiple deleterious
mutations combine together and thus reduces the effectiveness of natural selection in removing these deleterious
mutations, whereas negative epistasis can lower average mutational load by efficiently purging deleterious mutants [5].
As a consequence, selective elimination of deleterious mutations would be especially effective if negative epistasis is
prevalent. It is important to understand the distribution of epistasis among mutations, which plays a central role in
genetics and theoretical descriptions for many evolutionary processes [3, 4].
Tremendous efforts have been put into genome-wide measurements for the sign and magnitude of epistasis among
different genes in various species [6–17]. A series of high-throughput experimental platforms have been developed,
such as synthetic genetic array (SGA; Costanzo et al. 6, Tong et al. 7), diploid-based synthetic lethality analysis with
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microarrays [8, 9], synthetic dosage-suppression and lethality screen [10–12], and epistatic miniarray profiles [13–15].
The epistatic relations in these experiments were mostly measured based on one mutant type (deletion mutant) per
gene. Few studies constructed multiple mutant alleles for single genes to examine the dynamics of epistatic relations
among genes under different genetic perturbations. As a consequence, the global landscape of epistasis for different
alleles of the same gene remains largely uninvestigated.
We address this issue by exploring epistatic differences among alleles in the same gene for a large part of the
genome by combining experimental data with mathematical modeling using flux balance analysis (FBA). FBA involves
the optimization of cellular objective functions and allows prediction of in silico flux values and/or growth [18–20].
FBA has been used to investigate the fitness consequence of single-deletion mutants [21, 22] and epistatic relations
between metabolic reactions, genes, and functional modules [23–26]. The FBA predictions show good agreement with
genome-wide experimental studies [27–34]. One essential advantage of FBA modeling is that it can simulate epistasis
between genes based on different genetic mutants. Using this platform, together with data from a recently published
experiment [6], we were able to show that epistasis can be rewired among genes, and that the sign of epistasis can
change dramatically at the global scale, depending on the mutant alleles involved in the processes. Our study provides
a genome-wide picture on the dynamic epistatic landscape of various mutant alleles for the same gene.
2 Results
2.1 Epistatic Relations Between Genes Are Largely Allele-Specific.
We first used the yeast Saccharomyces cerevisiae metabolic reconstruction iMM904 [18] to examine the distribution
of epistasis under various genetic mutant alleles. The reconstruction is a genome-scale metabolic model, having 904
metabolic genes associated with 1,412 reactions. For each gene, we simulated genetic perturbations that retain the
corresponding flux from 90% to 0% in decrements of 10% of its WT (optimal) flux. As a result, 10 different single
mutants per nonessential gene and nine different single mutants per essential gene (the 0% flux mutants in these
genes represent lethal deletion for which epistasis cannot be calculated) were simulated. We computed the fitness of
the single mutants and double mutants with any possible pairwise allele combination of different genes. These data
were used to infer the epistatic relationships among genes. In total, over 40 million simulations were conducted. To
investigate the dynamics of epistasis among genes, we calculated the percentage of shared epistatic interaction partners
between any two mutants within the same gene. Two mutant alleles are defined to share an epistatic interaction partner
(a mutant from another gene) if they both epistatically interact with this mutant and the signs of epistasis are the same.
The percentage of shared epistatic interaction partners between two mutants is calculated as the number of their shared
epistatic interaction partners divided by the sum of their total epistatic interaction partners. As shown in Figure 1A,
our results indicate that the percentage of shared epistatic interaction partners between two mutants of the same gene
decreases as the flux difference between them increases. Two mutants of the same genes could have as low as only
about 20% overlap between their epistatic interaction partners, indicating that the epistatic profile of a gene is largely
dependent on the mutant types used. Our results also show that the average number of epistatic interaction partners
per gene do not affect this conclusion (Figure 5). Interestingly, there are cases where the sign of epistasis between
two genes can even change under varying mutant types (an example is in Figure 6, and all pairs with reversed sign
of epistasis are listed in Dataset S1). However, such events are rare (about 1.2% of all gene pairs that show epistatic
interactions). Furthermore, we repeated the above FBA analysis for another species, Escherichia coli, and the results
confirmed the above trend (Figure 7).
In a recently released high-throughput experiment that measured genome-wide epistatic relations among genes in
S. cerevisiae [6], there were 43 mutant pairs having two different mutant alleles of the same gene (Dataset S2), each
of which were experimentally crossed with 3,885 array gene deletion mutants to explore their epistatic relations in
the genome. In total, over 200,000 double mutants were experimentally constructed. This dataset provides the most
comprehensive experimental source for investigating the epistatic landscape of different mutant alleles in the same
gene. Figure 1B shows the empirical cumulative distribution for the percentage of shared interaction partners between
mutant pairs within the same gene. Our results indicate that more than 50% of mutant pairs within the same gene have
less than 10% overlap of their epistatic interaction partners, and about 90% mutant pairs have less than 20% overlap
(Figure 1B). As shown in Dataset S2, the functions of genes used in the experiments are very diverse, and not restricted
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Figure 1: Epistatic relations between genes are allele specific. (A) FBA simulation results for the distribution of the
percentage of shared epistatic interaction partners between two mutant alleles within the same gene. Solid and broken
lines represent mean and 95% confidence intervals, respectively. (B) The cumulative distribution for the percentage of
shared epistatic interaction partners between two mutant alleles within the same gene based on real experimental data.
Two broken lines represent 10% and 20% of shared epistatic profiling, respectively.
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to metabolic functions as genes in the FBA model. Nevertheless, the result from experimental studies confirms our
FBA modeling prediction that different mutant alleles of the same gene can have very distinct epistatic interaction
partners in the genome. In addition, the conclusions are robust under various epistasis thresholds (Figure 8).
2.2 Sign of Epistasis for Individual Genes Depends on Mutation Severity.
The relative prevalence of positive vs. negative epistasis is of tremendous importance for understanding many evo-
lutionary processes [3–5]. In the following we addressed this issue for different alleles of the same gene. Based on
the above high-throughput experimental dataset, we calculated the percentage of negative epistasis for each mutant,
defined as the number of negative epistatic partners for this mutant divided by the overall number of its epistatic part-
ners. We then compared the percentage of negative epistasis between different mutant alleles of the same gene in the
experiment. Among 43 mutant pairs in the study, 35 mutant pairs have significantly different fitnesses between two
mutants of the same gene. As shown in Figure 2.2A left, 21 mutant pairs (60%) show that alleles with more severe
defects have a higher chance than the other allele in the same gene to develop negative epistasis in the genome.
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Figure 2: Mutant alleles in the same gene with more severe defects tend to have a higher percentage of negative
epistasis in yeast. (A) The two matrices represent all mutant pairs identified in real experimental data (left) and FBA
simulation (right) (fitness difference |∆ f | ≥ 0.01; epistasis threshold |ǫ| ≥ 0.01). Each cell represents one mutant pair
within the same gene. The color bar to the right represents the normalized percentage of negative epistasis for the
mutant allele with more severe defects (percentage of negative epistasis for the mutant allele with more severe defects
divided by the sum of percentage of negative epistasis for two mutant alleles). Red and yellow colors represent that
mutant allele with more severe defects in the same gene has higher and lower percentage of negative epistasis than the
other allele, respectively. (B) Distribution for the number of mutant pairs among randomly selected 35 pairs where
mutants with more severe defects have higher percentage of negative epistasis. The arrow represents the observed
number for the mutant allele pairs within the same genes. (C) The percentage of mutant pairs in which the mutant
allele with more severe defects in the same gene has a higher percentage of negative epistasis under various fitness
difference and epistasis thresholds during FBA simulations.
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To see if this result could be caused by a systematic trend in the high-throughput experiments, we randomly selected
35 pairs of mutants from distinct genes that have the same fitness level for single-deletion mutant and fitness difference
between two mutants as the above 35 pairs of mutants within the same genes, and compared their relative prevalence
of negative epistasis. The permutation was repeated 100,000 times, and the result is depicted in Figure 2.2B. Among
all repeats of randomly selected 35 mutant pairs, only a small percentage (4.1%) have 21 or more mutant pairs where
the mutant with more severe defects has a higher chance than the other mutant to develop negative epistasis in the
genome, indicating that our observation for different mutant alleles of the same gene is not likely caused by the overall
pattern in the high-throughput experiments.
Using results from the above FBA simulation, we also confirmed the same pattern that between mutant alleles of the
same gene, the mutant allele with more severe defect is more likely than the other allele to develop negative epistasis
in the genome (Figure 2.2A, right). Indeed, an even higher percentage of mutant allele pairs in the FBA simulation
(about 70%) than in real experiments (60%) support this conclusion. To avoid possible bias from the definition of
epistasis and fitness differences between mutant alleles in the FBA simulation, we repeated the calculations based on
multiple criteria and our conclusion remains the same (Figure 2.2C).
Our observation is surprising given that previous results based on virus models or gene network simulations pro-
posed a totally opposite pattern at the genome level, i.e., mutations with larger mutational defects are more likely to
develop positive epistasis [35–39]. We further used the FBA simulations to explore the dynamics of epistasis for vari-
ous mutant alleles of the same gene in different species. High-quality genome-wide metabolic networks in three bacte-
ria (Escherichia coli [40], Salmonella typhimurium [41], and Helicobacter pylori [42]), one archaea (Methanosarcina
barkeri [43]), and another single-cell eukaryote (Plasmodium falciparum [44]) were used in our simulation. As shown
in Figure 3, when two mutant alleles of the same gene are compared, in 22%, 17%, 32%, and 19% of cases for E.
coli, S. typhimurium, H. pylori, and M. barkeri, respectively, mutant alleles with more severe defects display higher
percentages of negative epistasis than the other allele, indicating that more deleterious mutant alleles in the same
gene indeed tend to develop positive epistasis in these species. However, these numbers are significantly smaller than
that of yeast and another eukaryotic organism, P. falciparum (52%). The conclusion is robust under various epistasis
thresholds (Figure 9).
2.3 Self-Purging Mechanism for Deleterious Mutations at the Population Level
Our above results indicate that between two random mutant alleles of the same gene, the chance for the allele with
more severe mutational consequence to develop a higher percentage of negative epistasis than the other allele is 50-
70% in eukaryotic organisms, but only 20-30% in bacteria and archaea. In other words, mutant alleles with more
severe defects in the same gene might have a higher chance to develop negative epistasis in eukaryotic organisms
than in bacteria and archaea. We constructed a simple population genetic model as in Figure 2.3A to address the
evolutionary significance of this observation. The genetic system has two genes: a query gene A, which contains three
different alleles (AS: mutants with severe defects; AD: mutants with weak defects; AWT: WT), and a gene X, which
has two different alleles (mutant, XM, and WT, XWT). We simulated the ratio of allele frequency between the severe
and the weak mutant alleles in gene A under different probabilities of having negative epistasis between these two
alleles and the mutant allele in the gene X.
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Figure 3: Mutant alleles with more severe defects tend to have a higher percentage of negative epistasis in eukaryotes
than bacteria and archaea. The y axis shows the percentage of mutant pairs in which mutant alleles with more severe
defects in the same gene have a higher percentage of negative epistasis than the other allele. FBA simulations were
conducted for three bacterial species (E. coli, S. typhimurium, and H. pylori), one archaea species (M. barkeri), and
two single-cell eukaryote species (P. falciparum and S. cerevisiae). The mean and SEs were based on results from 40
epistasis threshold values ranging from 0.01 to 0.05.
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Figure 4: Increased efficiency of purging deleterious mutations in eukaryotic organisms. (A) The population genetics
model for allele frequency changes from generation to generation. In the figure, ρ and ω represent allele frequency
and fitness, respectively. A and X are genes with different alleles, and ǫ is the epistasis term between mutant types of
different genes. (B) The ratio of the severe to the weak alleles of the A gene in the 50th, 100th, 150th, 200th, 250th,
and 300th generations. Colors represent the ratio as indicated at the bottom. The diagonal line in each panel represents
the situation where the severe and the weak mutant alleles have the same probability of having negative epistasis in the
genome. It is noteworthy to point out that in each panel the ratio of the severe to the weak alleles decreases, indicating
increased efficiency of purging the severe mutant allele, from the upper right (region I, the weak mutant has more
negative epistasis) to the bottom left (region II, the severe mutant has more negative epistasis) part of the panel. The
arrows A and B are discussed in the text.
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Our results in Figure 2.3B depict the simulation results. The six panels in the figure represent the ratio of AS to
AD alleles in the 50th, 100th, 150th, 200th, 250th, and 300th generations, respectively. Our simulations indicate that if
the percentage of negative epistasis for the severe mutant is kept as a constant, as the percentage of negative epistasis
for the weak mutation increases (as shown by the arrow A), the ratio of the severe to the weak allele frequency would
increase. However, this ratio would decrease, indicating a faster removal of the severe mutants from the population,
in another direction (as shown by the arrow B), i.e., the percentage of negative epistasis for the weak mutant is kept as
a constant, but the percentage of negative epistasis for the severe mutant increases. Therefore, the distribution for the
sign of epistasis among different alleles of the same gene observed in this study might represent an efficient way for
eukaryotic organisms to purge deleterious mutations from populations.
3 Discussion
Our study represents a genome-wide theoretical survey for the dynamics of global epistatic effects under various mu-
tant alleles of the same gene. We show that the epistatic profiling of a gene at the genome level is largely dependent on
mutant types involved. Our results indicate that previous conclusions inferring epistatic relations among genes based
on only one mutant type per gene can be greatly improved by using multiple mutant alleles. More importantly, our
study shows that mutant alleles with severe defects have a higher chance to develop negative epistasis in eukaryotic
organisms than in bacteria and archaea. It has been speculated that eukaryotic organisms might have more nega-
tive epistasis due to their increased complexity over prokaryotic organisms [45, 46]. Even if this hypothesis is true,
however, our results for different mutant alleles of the same gene cannot be directly inferred from this complexity
argument.
Even though the mechanism underlying our observation remains to be determined, we argue that such distributions
for negative epistasis among different alleles of the same genes have significant evolutionary consequences, as shown
in our population genetics simulations (Figure 2.3). The origin and maintenance of sexual reproduction remains one
of the central issues in evolutionary biology. Population genetics models have been proposed to explore the impact
of epistasis on the maintenance of sexual reproduction [47–50]. The mutational deterministic hypothesis posits that
sex enhances the ability of natural selection to purge deleterious mutations by bringing them together into single
genome through recombination [47]. This explanation requires the prevalence of negative epistasis at the genome
level. Here we found that the mutations with larger deleterious defects within the same gene have a higher chance to
develop negative epistasis in eukaryotic organisms than bacteria and archaea. The model we proposed in Figure 2.3,
which is based on the population genetics theory from Kondrashov [47], indicates that such distribution of negative
epistasis among different alleles of the same gene in eukaryotic organisms might lead to more efficient purging of
deleterious mutations from populations, thus providing a previously unappreciated evolutionary advantage for sexual
reproduction. We emphasize that these findings do not necessarily provide sufficient evidence to explain the cause for
the emergence of sexual reproduction during evolution.
Although we found several unique characteristics regarding the global epistatic landscape of different mutant
alleles in the same gene, three caveats need to be addressed. First, the FBA modeling used in this study, which has
been successfully applied to various research problems [21–26], includes only metabolic genes in the simulation.
However, results from our analysis on the experimentally defined epistatic relations among roughly 0.2 million double
mutants comprising about 4,000 S. cerevisiae genes, which nearly represent all functional categories in the budding
yeast, confirmed our major FBA modeling predictions.
Second, even though FBA is one of the most comprehensive computational tools for simulating epistatic inter-
actions among genes, there are still many aspects that can be improved to aid in capturing the full set of empirical
genetic interactions [51]. For example, rules for transcriptional regulation and physical interactions can be integrated
into the current FBA framework to improve its accuracy [52]. In addition, mapping between individual alleles and
metabolic flux reduction is a complex process and difficult to measure experimentally [53]. It is noteworthy that in
our simulations we have uniformly evaluated fitness consequence based on the percentage of WT flux attainable in
a specific background. Depending on the regulation dynamics of individual genes, such uniform sampling may be
unlikely to correspond to random sampling of mutant alleles. For instance, a mutation that limits the availability of
a ligand that activates an enzyme following a Hill equation with early saturation may have a very high frequency of
neutral or mildly deleterious mutations compared with a similar enzyme with late saturation. Nevertheless, uniform
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sampling in our study is still useful in illustrating the main evolutionary ideas presented here, which all have to do
with relative severity of mutations rather than their absolute fitness.
Third, measuring the presence of epistasis is subject to a choice of threshold. Does the flux smoothly influence
epistasis, or can epistasis abruptly change or become zero? We have seen evidence of both trends in our simulations.
Though there are many different trends in the magnitude of epistasis that we are currently investigating, we present
two cases to explore this issue (Figures 10 and 11 and Datasets S3 and S4). However, based on Figure 8 and 9, we
have confirmed that our major results are robust to a variety of epistasis thresholds. As a result, although the choice
of thresholds is a common problem for research on epistasis, we are still confident that our conclusion is unlikely to
be significantly influenced by this factor. With these limitations in mind, our observations identified several important
features for the epistasis among genes, and call on future experimental and theoretical efforts to revisit genetics and
evolutionary theories that can integrate epistatic dynamics among genes in biological systems.
4 Methods
4.1 Experimental Dataset
The experimental data were extracted from a global survey for the epistatic interactions among genes in S. cerevisiae
[6]. In this original SGA study, the authors screened 1,712 S. cerevisiae query gene mutants against 3,885 array gene
mutants to generate a total of more than 5 million gene mutant pairs spanning all biological processes. In each gene
mutant pair, the epistasis value is calculated based on the equation ǫ = Wxy − WxWy, in which Wxy is the fitness of an
organism with two mutations in genes X and Y, and Wx or Wy refers to the fitness of the organism with mutation only at
gene X or Y, respectively. In addition, a statistical confidence measure (p-value) was assigned to each interaction based
on the observed variation of each double mutant across four experimental replicates and estimates of the background
error distributions for the corresponding query and array mutants. Finally, a defined confidence threshold (|ǫ| ≥ 0.01,
P < 0.05) was applied to generate epistatic interactions [6].
4.2 Flux Balance Analysis
FBA frames the stoichiometric equations that describe the biological reactions of a system as the following matrix
equations, which is possible because stoichiometric equations are linear [18–20].
maximize cT v
subject to Sv = dxdt = 0
vlb  v  vub
(1)
The vector of concentration change over time ( dxdt ) is found by multiplying the stoichiometric matrix S by a flux
vector v. S has columns corresponding to each reaction in the system, and rows corresponding to metabolites. Typ-
ically, one or more enzymes correspond to each reaction, which allows us to see how a genetic perturbation, such as
a knockout, may affect the system. The vector v consists of reaction fluxes and is subject to upper and lower bounds
vub = (u1, u2 . . . , un)T and vlb = (l1, l2 . . . , ln)T . If we want to simulate the knockout or knockdown of an enzyme, the
fluxes corresponding to that enzyme can be constrained to be zero or lower than WT, respectively. It is assumed that
the change in concentration over time is at steady state, therefore dxdt = 0 in the FBA simulation [20].
The linear objective is written in terms of the vi with weight coefficients ci. Modified versions of COBRA and
COBRA2 scripts, popular FBA software packages written for MATLAB, were used to implement our simulation
framework [19]. The method for calculating a realistic WT flux for a given environment and organism model is taken
from Smallbone and Simeonidis 20. This method, termed geometric FBA, attempts to choose a flux vector that is
close to the average of all optimal flux vectors. The geometric FBA solution is also a minimal L1-norm solution,
which has been previously heralded as a good choice because it minimizes the total amount of flux needed to achieve
the objective, based on the fact that cells would avoid having much unnecessary flux and wasted energy [20]. A
minimal L1-norm solution is advantageous in this study because restricting fluxes for mutants based on unnecessarily
large WT fluxes may not constrain the system. Finally, the minimal L1-norm solution avoids the problem of having
futile cycles, which are thermodynamically infeasible [20].
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Mutations of genes are simulated by the use of gene-reaction mapping and flux constraints. Enzymes may be
involved in multiple reactions (i.e., pleiotropy). Although we often have Boolean rules describing the relationship
between genes in an enzyme complex, it is currently extremely difficult to ascertain the exact contribution of each
enzyme to each reaction [53]. Choosing the simplest unbiased approach, we used gene-reaction mapping and uni-
formly constrained the flux through each reaction associated to the gene being mutated. With one notable exception
[26], most research relating to simulation of mutations with FBA has focused on null mutants [21–25, 27, 28]. Our
simulation approach, though simplifying the actual dynamics that result in decreased fluxes in vivo, allows us to see
behavior that was not previously possible. To be consistent, we used the same equation and threshold (|ǫ| ≥ 0.01) to
calculate epistasis for FBA results as we did for the experimental data.
4.3 Population Genetics Model
A flowchart in Figure 12 provides more illustration of the simulation procedure. We constructed a genetic system with
a query gene A, which contains three different alleles (AS: severe mutant; AD: weakly deleterious mutants; and AWT:
WT) and a gene X that has two different alleles (XM: mutant and XWT: WT). The table in Figure 2.3A explains how
genotype frequencies could be calculated from generation T to generation T + 1 under natural selection. In the figure,
ρ and ω represent allele frequency and fitness, respectively. The average fitness in generation T could be calculated
[54]. We simulated the ratio of allele frequency for the severe (AS) to the weak (AD) mutant alleles of the A gene under
all possible combinations of the percentages of negative epistasis for these two alleles, as shown on the x and y axis
of Figure 2.3B. For each possible combination in each generation (a specific location on each panel of Figure 2.3B),
the following two-step procedure was repeated 1,000 times. First, the epistatic relations (negative, positive, and no
epistasis) between the mutant alleles of the genes A and X were randomly determined as the following: either A allele
is assumed to have 10% possibility of having epistasis (either positive or negative) with the allele XM [6]; when A and
X alleles do have epistasis, the likelihoods for the epistasis being negative (and the remaining epistases are positive)
are assigned independently for AS and AD alleles according to their location on Figure 2.3B. Second, the fitness of
each genotype was calculated, which was then used to infer the genotype frequencies in the next generation according
to Figure 2.3A. The average genotype frequencies among 1,000 randomizations were then recorded for simulations
in the next generation. The ratio of allele frequency for the severe to the weak mutant alleles of the A gene in each
generation was calculated based on genotype frequencies in that generation.
To make the simulation simple, the initial allele frequencies for the severe, weak, and WT alleles of the A gene
were assumed to be equal (one-third), and the initial allele frequencies for the mutant and WT of the X gene were also
assumed to be equal (one-half). The fitness was assumed to be 1, 0.99, and 0.98 for the WT, weak, and severe mutant
alleles of gene A, respectively, and 1 and 0.99 for the WT and the mutant alleles of gene X, respectively. The positive
and negative epistasis values between A and X gene mutants were assumed to be 0.01 and 0.01, respectively. A variety
of fitness differences between the severe and weak alleles and epistasis values have also been used in the simulations,
and the trend remains the same.
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Figure 5: The conclusion in Fig. 1 is not dependent on the average number of epistatic interaction partners per gene.
(A) The distribution of average number of epistatic interaction partners per gene. For each gene with epistasis, its
average number of epistatic interaction partners was calculated among all mutant alleles of this gene. (B-D) A similar
conclusion to that of Fig. 1 can be obtained when we only use genes with fewer than 500 (B), 500-2,000 (C), and more
than 2,000 (D) average epistatic interaction partners. The same methods in Fig. 1 were used here to generate B-D.
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Figure 6: A complex epistatic landscape exhibits a transition from large positive to large negative epistasis values,
along with a region of zero epistasis. Epistasis is viewed as a function of the CTP1 and ARO3 genes flux restriction.
The color corresponds to the z-axis (epistasis), with red being more positive, green being near zero, and blue being
more negative.
15
Figure 7: Percentage of shared epistatic interacting partners based on flux differences between two mutant alleles of
the same gene. The analysis procedure is the same as Fig. 1A, but instead of using the S. cerevisiae model, here we
repeated the analysis using the E. coli model (38).
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Figure 8: The conclusion that epistatic relations between genes are allele-specific is robust to various epistasis thresh-
olds. Left 5 panels: The FBA simulation results for the distribution of the percentage of shared epistatic interaction
partners between two mutant alleles within the same gene. Solid and broken lines represent mean and 95% confidence
intervals, respectively. Right 5 panels: The cumulative distribution for the percentage of shared epistatic interaction
partners between two mutant alleles within the same gene based on real experimental data. Both experimental and
simulated results are robust under various epistasis thresholds.
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Figure 9: The conclusion in Fig. 3, for which mutant alleles with more severe defects tend to have a higher percentage
of negative epistasis in eukaryotes than bacteria and archaea, is robust under various epistasis and fitness difference
thresholds. The same methods to generate Fig. 2C for S. cerevisiae are used here for the other five species.
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Figure 10: An epistatic landscape exhibits smooth change in epistasis as a function of the flux restriction for the genes
HXT13 and ADE1. The color corresponds to the z-axis (epistasis), with red being more positive, and green being
near zero. See dataset S3 for simulated data. HXT13 is a hexose transporter and ADE1 is required for de novo purine
biosynthesis. The epistasis surface for HXT13 and ADE1 is quite smooth, which is a fairly common pattern and we
may infer that epistasis, at least in metabolism, is often dependent on thresholds.
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Figure 11: An epistatic landscape exhibits a sharp transition to zero epistasis, primarily as a consequence of the THR4
flux restriction. The color corresponds to the z-axis (epistasis), with red being more positive, and green being near
zero. See dataset S4 for simulated data. Epistasis is examined between threonine synthase gene THR4 and COX1
(subunit 1 of cytochrome c oxidase). Both genes are associated with mutually exclusive reactions. As shown in the
figure, there are regions where the epistasis is effectively zero (on the order of 10-5) where the THR4 single mutant
growth rate has only changed very slightly, effectively allowing the mutations to act independently. Once the THR4
mutant becomes more severe, the effects are no longer independent.
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Figure 12: A flow chart to illustrate the simulation process that generates Fig. 4B. This procedure included 5 steps
as indicated in the 5 blue boxes, and we have repeated step 2 to step 5 in the simulation to produce all possible allele
combinations, as highlighted in the red box.
21
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